Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rain Oncology (RAIN)
NASDAQ:RAIN
Holding RAIN?
Track your performance easily
RAIN Stock Chart & Stats
Day’s Range$1.21 - $1.27
52-Week Range― - ―
Previous Close$1.23
Volume3.71M
Average Volume (3M)N/A
Market Cap
$54.67M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.39Price Target Upside14.88% Upside
Rating ConsensusHold
Number of Analyst Covering4
Rain Oncology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RAIN FAQ
What was Rain Oncology’s price range in the past 12 months?
Currently, no data Available
What is Rain Oncology’s market cap?
Currently, no data Available
When is Rain Oncology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rain Oncology’s earnings last quarter?
Currently, no data Available
Is Rain Oncology overvalued?
According to Wall Street analysts Rain Oncology’s price is currently Undervalued.
Does Rain Oncology pay dividends?
Rain Oncology does not currently pay dividends.
What is Rain Oncology’s EPS estimate?
Rain Oncology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rain Oncology have?
Currently, no data Available
What happened to Rain Oncology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rain Oncology?
Among the largest hedge funds holding Rain Oncology’s share is HealthCor Management, L.P.. It holds Rain Oncology’s shares valued at 103K.
---
Rain Oncology Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.39 (14.88% Upside)
$1.39 (14.88% Upside)
Blogger Sentiment
Bullish
RAIN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 353.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $209.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.6%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.52%
12-Months-Change
Fundamentals
Return on Equity
-97.04%
Trailing 12-Months
Asset Growth
-13.29%
Trailing 12-Months
Company Description
Rain Oncology
Rain Therapeutics Inc is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which they are able to genetically select patients they believe will most likely benefit. Its lead product candidate, RAIN-32 is a small molecule, oral inhibitor of mouse double minute 2, which is oncogenic in numerous cancers.
---
RAIN Stock 12 Month Forecast
Average Price Target
$1.39
▲(14.88% Upside)
Technical Analysis
Gilead Sciences
―
Ionis Pharmaceuticals
―
Jazz Pharmaceuticals
―
Karyopharm Therapeutics
―
---